Observational analysis reveals potential of SVF and exosomes in osteoarthritis treatment, suggesting new therapeutic pathways.
Regenerative medicine and osteoarthritis: SVF, exosomes and beyond Torbjörn Ogéus from Stockholms Led- & Smärtspecialist guides us through the evolving science of stromal vascular fraction, exosomes, and beyond in regenerative medicine and osteoarthritis. Osteoarthritis (OA), a chronic degenerative joint condition, affects hundreds of millions worldwide and remains a leading cause of disability and reduced quality of life. While traditional treatments focus on symptom control – primarily pain management and surgical intervention – the field of regenerative medicine is rapidly rewriting the narrative.
No takes yet. Share an insight, caveat, or question.
Torbjörn Ogéus (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: